Final Analysis of a Phase I/IIa Study With CV9103, an Intradermally Administered Prostate Cancer Immunotherapy Based on Self Adjuvanted mRNA

Titel:: Final Analysis of a Phase I/IIa Study With CV9103, an Intradermally Administered Prostate Cancer Immunotherapy Based on Self Adjuvanted mRNA
Dokumenttyp:: Meeting Abstract
Autor(en):: Kubler, H; Stenzl, A; Schultze-Seemann, W; Dorp, FV; Pilla, L; Hampel, C; Jocham, D; Development, C; Miller, K
Zeitschriftentitel:: Eur J Cancer
Jahr:: 2011
Band / Volume:: 47 1
Seitenangaben Beitrag:: S498-S499
Sprache:: eng
Print-ISSN:: 0959-8049
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: